Inventor

MOFFAT DAVID FESTUS CHARLES

GB30 patents

⚠️ This page may combine multiple inventors who share the name “MOFFAT DAVID FESTUS CHARLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MOFFAT DAVID FESTUS CHARLES

CELLTECH THERAPEUTICS LTD

Substituted 2-pyrimidineamines and processes for their preparation

Substituted 2-anilinopyrimidines useful as protein kinase inhibitors

Substituted 2-anilinopyrimidines useful as protein kinase inhibitors

Substituted 2-anilinopryimidines useful as protein kinase inhibitors

Substituted 2-anilinopyrimidines useful as protein kinase inhibitors

2-Pyrimidineamine derivatives and processes for their preparation

Fused polycyclic 2-aminopyrimidine derivatives

5-aminopyrazoles useful as tyrosine kinase inhibitors

Fused polycyclic 2-aminopyrimidine derivatives

CHROMA THERAPEUTICS LTD

Histone deacetylase inhibitors

IKK-beta serine-threonine protein kinase inhibitors

Hydroxamic acid derivatives as inhibitors of HDAC enzymatic activity

Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof

Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereof

Enzyme inhibitors

2-aminopyrazine derivatives as CSF-1R kinase inhibitors

CELLTECH R&D LTD

5-cyano-2-aminopyrimidine derivatives

4,5-disubstituted-2-aminopyrimidines

2-pyrimidineamine derivatives and processes for their preparation

Fused polycyclic 2-aminopyrimidine derivatives

Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases

GLAXOSMITHKLINE IP DEV LTD

Methods of treating lymphoma and rheumatoid arthritis with cyclopentyl (2S)-cyclohexyl[({6-[3-(hydroxyamino)-3-oxopropyl]pyridin-3-yl}methyl)amino]acetate

Enzyme and receptor modulation using covalent conjugates of alpha,alpha-disubstituted glycine esters

HDAC inhibitors

MOFFAT DAVID FESTUS CHARLES

Adenine derivative as inhibitors of HSP90 for the treatment of cancer

Inhibitors of P38 map kinase

MACROPHAGE PHARMA LTD

Treatment of cancer by stimulation of IL-12 production

Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-YL]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof

DAVIDSON ALAN HORNSBY

Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity

DONALD ALASTAIR DAVID GRAHAM

Benzamide derivatives and their use as HSP90 inhibtors